Porcilis M Hyo

Description and Vaccination Program

Active ingredients
Inactivated whole-cell concentrate of Mycoplasma hyopneumoniae strain 11 incorporated in an adjuvant based on dl-α-tocopherol acetate (Diluvac Forte) to prolong immune stimulation. Each dose contains ≥ 2^7.0 Ab titre*.
* Mean antibody titre (Ab) obtained after inoculation of mice with a 1/20th of a pig dose.

Indication
For the active immunisation of (finishing) pigs to reduce pulmonary lesions due to infection by Mycoplasma hyopneumoniae .

Vaccination program
Two doses with a three week interval between, beginning as early as 1 week of age.

Published data has shown that the efficacy of Porcilis PRRS and Porcilis M Hyo is equal whether given individually or both at the same time.

Immunity
Onset of immunity: 2 weeks after the second dose.
Duration of immunity: At least 20 weeks after the second dose.

Dosage and method of administration
Each dose: 2ml by intramuscular injection in the neck, behind the ear.

Pharmaceutical precautions

• Store between +2°C and +8°C. Do not freeze.
• Allow the vaccine to reach room temperature (15-25°C) before use.
• Shake well before use.

Presentation
Porcilis M Hyo is available in 10, 50 and 100 dose presentations.
Not all pack sizes may be marketed in all countries.

Porcilis M hyo

Vaccinator